CCL5 and breast carcinoma: However, tumor-derived CCL5 does not act as the significant contributor to mammary carcinoma growth [42], and hematopoietic-derived CCL5 promotes tumor progression via the generation of MDSCs and maintenance of its immunosuppressive properties [41].